focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Share News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 731.00
Bid: 732.00
Ask: 736.00
Change: -9.00 (-1.22%)
Spread: 4.00 (0.546%)
Open: 725.00
High: 750.00
Low: 725.00
Prev. Close: 740.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: BP promises buyback despite drop in profit

Tue, 06th Feb 2024 07:47

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Retail sales growth in the UK slowed in January, data from the British Retail Consortium and KPMG showed Tuesday. Total retail sales in the UK between December 31 and January 27 grew by 1.2% year-on-year, decelerating from growth of 4.2% in January a year ago.

In early corporate new, oil major BP has announced a new buyback, despite a drop in quarterly and annual profit

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.7% at 7,665.00

----------

Hang Seng: up 4.0% at 16,128.15

Nikkei 225: closed down 0.5% at 36,160.66

S&P/ASX 200: closed down 0.6% at 7,581.60

----------

DJIA: closed down 274.30 points, 0.7%, at 38,380.12

S&P 500: closed down 15.80 points, 0.3%, at 4,942.81

Nasdaq Composite: closed down 31.28 points, 0.2%, to 15,597.68

----------

EUR: up at USD1.0752 (USD1.0728)

GBP: up at USD1.2551 (USD1.2527)

USD: down at JPY148.43 (JPY148.80)

Gold: up at USD2,026.98 per ounce (USD2,019.86)

(Brent): up at USD78.06 a barrel (USD77.11)

(changes since previous London equities close)

----------

ECONOMICS

----------

Tuesday's key economic events still to come:

08:30 EST Canada building permits

10:00 EST Canada Ivey PMI

13:00 EST Canada Bank of Canada Governor Tiff Macklem speaks

09:30 CET eurozone construction PMI

11:00 CET eurozone retail sales

11:00 CET eurozone consumer inflation expectations

09:30 CET France construction PMI

08:00 CET Germany factory orders

09:30 CET Germany construction PMI

09:30 CET Germany new car registrations

09:30 GMT UK construction PMI

08:55 EST US Redbook index

----------

Retail sales growth in the UK slowed in January, data from the British Retail Consortium and KPMG showed Tuesday. Total retail sales in the UK between December 31 and January 27 grew by 1.2% year-on-year, slowed down from growth of 4.2% in January 2023. Food sales growth decelerated to 6.3% over the three months to January, down from 8.0% a year prior. Meanwhile, non-food sales fell by 1.8% annually over the three months to January. Helen Dickinson, chief executive of the British Retail Consortium, said: "Easing inflation and weak consumer demand led retail sales growth to slow. While the January sales helped to boost spending in the first two weeks, this did not sustain throughout the month. Larger purchases, such as furniture, household appliances, and electricals, remained weak as the higher cost of living continued into its third year. The milder temperatures meant clothing sales performed poorly, particularly winter clothing and footwear. It was better news for health and beauty products, which continued to sell extremely well."

----------

The Irish service sector lost all momentum at the start of 2024, amid a slowdown in new business, purchasing managers' index survey results from S&P Global showed on Tuesday. The AIB Ireland services business activity index fell to 50.5 points in January from 53.2 in December. Last month's reading was barely above the 50-point no-change mark and the weakest since March 2021. The average Irish services sector score during 2023 was a much stronger 55.5 points. "Irish firms continued to report rising levels of new business, but the pace of growth eased in January to the second weakest in 13 months," commented AIB Chief Economist David McNamara.

----------

BROKER RATING CHANGES

----------

Barclays cuts Entain to 'equal weight' (overweight) - price target 1,070 (1,120) pence

----------

Berenberg starts SThree with 'buy' - price target 550 pence

----------

COMPANIES - FTSE 100

----------

BP called 2023 "a year of delivery" on the back of its full-year results. In its fourth quarter, revenue fell to USD52.59 billion from USD70.36 billion a year earlier. The oil major reported that pretax profit fell to USD1.10 billion from USD16.90 billion. Over the whole year, revenue dropped to USD213.03 billion from USD248.89 billion on-year. Pretax profit fell to USD23.75 billion from USD15.41 billion. On the back of the results, BP paid out a quarterly dividend per share 7.27 US cents, up versus 6.61 US cents. This brings the full-year dividend to 28.42 cents, up from 24.08 cents. It said it has completed a USD1.5 billion share buyback on February 2, and now intends on initiating a USD1.75 billion buyback, prior to reporting its first quarter results. It intends to buy back USD3.5 billion in shares for first half of 2024. Chief Executive Murray Auchincloss said: "Looking back, 2023 was a year of strong operational performance with real momentum in delivery right across the business. And as we look ahead, our destination remains unchanged – from IOC to IEC – focused on growing the value of BP. We are confident in our strategy, on delivering as a simpler, more focused and higher-value company, and committed to growing long-term value for our shareholders."

----------

GSK said the Dreamm-7 phase 3 trial shows Blenrep combination nearly tripled median progression-free survival versus standard of care combination in patients with relapsed/refractory multiple myeloma. The pharmaceutical company noted a 59% reduction in risk of disease progression or death observed in patients with Blenrep combination versus standard of care daratumumab combination. Separately, GSK said its regulatory application for Shingrix for the prevention of shingles in at-risk adults aged 18 and over has been accepted for review by China National Medical Products Administration. Shingrix has already been approved in China for adults aged 50 years and over. Finally, GSK's RSV vaccine, Arexvy, has been accepted under priority review in US for the prevention of RSV disease in adults aged 50-59 at increased risk. Its application is supported by positive results of a phase 3 trial showing immune response and acceptable tolerability profile in this population.

----------

COMPANIES - FTSE 250

----------

Renishaw said that in the six months ended December 31, revenue fell 5% to GBP330.5 million from GBP347.7 million a year earlier. Statutory pretax profit fell 27% to GBP56.5 million from GBP77.8 million. On the back of the results, Renishaw left its dividend unchanged at 16.8p. CEO William Lee said: "We expect an improvement in our trading performance in the second half of the financial year as market conditions improve, and as we continue to pursue a range of growth opportunities. To support our through-cycle growth strategy, we are continuing to focus on productivity and to make targeted investments in our people, our production facilities, and our new product pipeline."

----------

discoverIE said it is on track to deliver full year underlying earnings in-line with the board's expectations, in a trading update on the four months ended January 31. The Guildford, Surrey-based customised electronics manufacturer and designer reported that orders in the period grew by 3% organically year-on-year. This is the first growth in orders since the quarter ending September 2022, discoverIE noted. Looking ahead, it said: "With a clear strategy focused on structural and sustainable international growth, a diversified customer base, a healthy order book and record pipeline of design wins and acquisition opportunities, the group has a resilient business model that, despite varied market conditions, is well positioned to make further good progress on its key priorities."

----------

OTHER COMPANIES

----------

Character Group said it will buy back up to GBP1.0 million in shares. It said it is part of its strategy to repurchase its shares "when considered appropriate." The Surrey, England-based toy, games and gifts maker added that it has appointed its joint corporate broker, Panmure Gordon (UK) Ltd to manage the buyback. The buyback programme can subsequently be increased in scale by agreement between the company and Panmure Gordon.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
14 Apr 2022 07:18

DiscoverIE FY underlying earnings expected to beat previous guidance

(Sharecast News) - Electronics manufacturer DiscoverIE said on Thursday that trading in the final two months of the year continued to be strong, with the group now expecting to deliver full-year underlying earnings from continuing operations ahead of previous guidance.

Read more
4 Mar 2022 09:41

IN BRIEF: discoverIE to redeploy funds after completing two disposals

discoverIE Group PLC - Guildford, Surrey-based maker of customised electronics, for sectors such as renewables and transport - Completes sale of electronic component distribution business, Acal BFi, to H2 Equity Partners. The GBP50.0 million deal was first announced in early November. It also notes the sale of Vertec SA to its management team, which was announced in October, completed in January. discoverIE says the proceeds will be used to reduce its debt and to "progress the design and manufacturing growth strategy".

Read more
4 Mar 2022 08:00

LONDON MARKET PRE-OPEN: Hammerson loss narrows; Mitie sees scrutiny

(Alliance News) - Stock prices are seen opening lower on Friday after scares of a nuclear disaster in Ukraine following direct shelling of a nuclear power plant, while a business group has downgraded its expectations for UK economic growth this year.

Read more
25 Feb 2022 11:13

IN BRIEF: discoverIE director buys GBP87,000 in shares

discoverIE Group PLC - FTSE-250 listed maker of customised electronics, for sectors such as renewables and transport - Non-executive Director Bruce Thompson buys 11,000 shares at GBP7.94 each, worth GBP87,340, on Wednesday.

Read more
9 Feb 2022 09:39

discoverIE lifts guidance amid strong trading and record order book

discoverIE lifts guidance amid strong trading and record order book

Read more
9 Feb 2022 07:03

DiscoverIE revenues and order book continue to improve

(Sharecast News) - Customised electronics manufacturer DiscoverIE Group said on Wednesday that strong trading momentum seen in the first half had carried over into the four months ended 31 January, with a further strengthening of the firm's order book and significant year-on-year revenue growth.

Read more
2 Feb 2022 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
7 Jan 2022 16:07

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
9 Dec 2021 14:44

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
30 Nov 2021 17:05

LONDON MARKET CLOSE: Stocks sink on Moderna's Omicron vaccine warning

LONDON MARKET CLOSE: Stocks sink on Moderna's Omicron vaccine warning

Read more
30 Nov 2021 09:31

discoverIE looks to beat annual expectations after healthy half-year

discoverIE looks to beat annual expectations after healthy half-year

Read more
30 Nov 2021 09:01

Discoverie H1 revenue and profits grow

(Sharecast News) - Electronic components manufacturer Discoverie said on Tuesday that both revenue and profits had grown in the six months ended 30 September, with the group now trading "well ahead" of pre-Covid levels.

Read more
23 Nov 2021 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Nov 2021 09:25

LONDON BROKER RATINGS: Stifel cuts Auto Trader to Hold from Buy

LONDON BROKER RATINGS: Stifel cuts Auto Trader to Hold from Buy

Read more
15 Nov 2021 09:33

LONDON BROKER RATINGS: RBC and Goldman Sachs downgrade B&M

LONDON BROKER RATINGS: RBC and Goldman Sachs downgrade B&M

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.